Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Targeting Caveolin-1 and Claudin-5 With Ay9944, Improve Blood–Brain Barrier Permeability; Computational Simulation and Experimental Study
Safura Jokar

Assistant Professor of Nuclear Pharmacy

Department Nuclear Pharmacy

School of Pharmacy

Tehran University of Medical Sciences

All Documents
1. Design of a New 99M99mtc-Radiolabeled Cyclo-Peptide As Promising Molecular Imaging Agent of Cxcr4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation, Current Radiopharmaceuticals (2024)
2. Self-Assembled Peptide/Polymer Hybrid Nanoplatform for Cancer Immunostimulating Therapies, Drug Delivery and Translational Research (2024)
3. X-Ray-Based Cancer Diagnosis and Treatment Methods, Electromagnetic Waves-Based Cancer Diagnosis and Therapy: Principles and Applications of Nanomaterials (2023)
4. Targeting Caveolin-1 and Claudin-5 With Ay9944, Improve Blood–Brain Barrier Permeability; Computational Simulation and Experimental Study, Cellular and Molecular Neurobiology (2022)
5. The Footprint of Exosomes in the Radiation-Induced Bystander Effects, Bioengineering (2022)
6. Design of Peptide-Based Inhibitor Agent Against Amyloid-Β Aggregation: Molecular Docking, Synthesis and in Vitro Evaluation, Bioorganic Chemistry (2020)
7. Design, Preparation and Biological Evaluation of a 177Lu-Labeled Somatostatin Receptor Antagonist for Targeted Therapy of Neuroendocrine Tumors, Bioorganic Chemistry (2020)
8. Preclinical Study of a New 177Lu-Labeled Somatostatin Receptor Antagonist in Ht-29 Human Colorectal Cancer Cells, Asia Oceania Journal of Nuclear Medicine and Biology (2020)
9. Synthesis, Biological Evaluation and Preclinical Study of a Novel 99Mtc-Peptide: A Targeting Probe of Amyloid-Β Plaques As a Possible Diagnostic Agent for Alzheimer's Disease, Bioorganic Chemistry (2020)
10. Recent Advances in the Design and Applications of Amyloid-Β Peptide Aggregation Inhibitors for Alzheimer’S Disease Therapy, Biophysical Reviews (2019)